Radiotherapy and cardiovascular toxicity
Srebot, V.; Sbrana, F.; Poggianti, E.; Pasanisi, E.
Recenti Progressi in Medicina 100(6): 299-303
2009
ISSN/ISBN: 0034-1193 PMID: 19708300 Document Number: 634967
The authors describe the case of a 41-year old patient, with multiple cardiovascular risk factors and past radiotherapic treatment at the chest and cervical region which developed a waste coronary and carotid atherosclerosis associated with aortic and mitralic valvular disease. The role of radiotherapy in developing cardiovascular diseases, in particular about valvular disease is discussed.
Document emailed within 1 workday
Related Documents
Romero, A.; Grau, M.T.; Villamayor, F.; Sacristán, A.; Ortiz, J.A. 1997: Toxicity of ebrotidine on reproduction. Toxicity on fertility and general reproductive performance, embryo-fetal toxicity and peri- and postnatal toxicity Arzneimittel-Forschung 47(4a): 504-510Rodrigues, G.; Lock, M.; D'Souza, D. 2007: Toxicity and health-related quality-of-life assessment in prostate radiotherapy Canadian Journal of Urology 14(4): 3608-3615
Hanssen, S.; Norum, J. 2008: Bladder and rectal toxicity of BeamCath application in radiotherapy of prostate cancer Anticancer Research 28(5b): 2865-2868
Nieder, C.; Jeremic, B.; Astner, S.; Molls, M. 2003: Radiotherapy-induced lung toxicity: risk factors and prevention strategies Anticancer Research 23(6d): 4991-4998
Jackson, W.K.; Roose, S.P.; Glassman, A.H. 1987: Cardiovascular toxicity and tricyclic antidepressants Biomedicine and PharmacoTherapy 41(7): 377-382
Takeda, K.; Ogawa, Y.; Ariga, H.; Koto, M.; Sakayauchi, T.; Fujimoto, K.; Narazaki, K.; Mitsuya, M.; Takai, Y.; Yamada, S. 2009: Clinical correlations between treatment with anticoagulants/antiaggregants and late rectal toxicity after radiotherapy for prostate cancer Anticancer Research 29(5): 1831-1834
Kouloulias, V.; Zygogianni, A.; Kantzou, I.; Tolia, M.; Platoni, K.; Antypas, C.; Chaldeopoulos, D.; Pantelakos, P.; Siatelis, A.; Chrysofos, M.; Beli, I.; Dilvoi, M.; Georgakopoulos, I.; Sarris, G.; Kouvaris, J.; Kelekis, N. 2014: A hypofractionated radiotherapy schedule with 57.75Gy in 21 fractions for T1-2N0 prostate carcinoma: Analysis of late toxicity and efficacy Journal of Buon: Official Journal of the Balkan Union of Oncology 19(3): 763-769
Forejtová, S. 2006: Problems of cardiovascular toxicity of coxibs and non-selective NSA Vnitrni Lekarstvi 52(7-8): 677-685
Reznikov, K.M. 1981: Changes in the toxicity of certain cardiovascular drugs as a result of hyperbaric oxygenation Farmakologiia i Toksikologiia 44(3): 342-346
Bhave, M.; Akhter, N.; Rosen, S.T. 2014: Cardiovascular toxicity of biologic agents for cancer therapy Oncology 28(6): 482-490
Thomas, R.D.; Behbehani, M.M.; Coyle, D.E.; Denson, D.D. 1986: Cardiovascular toxicity of local anesthetics: an alternative hypothesis Anesthesia and Analgesia 65(5): 444-450
Ledru, F.; Giraud, P.; Sapoval, M.; Lafont, A.; Gambini, D.; Gaux, J.C.; Guermonprez, J.L.; Housset, M. 2000: Use of radiotherapy in cardiovascular disease. Radiophysical basis, current results, indications and perspectives Archives des Maladies du Coeur et des Vaisseaux 93(9): 1125-1138
Flentje, M.; Mende, U.; Weischedel, U.; Wieland, C. 1988: Results of radiotherapy in advanced oropharyngeal carcinomas. Primary and postoperative radiotherapy versus radiotherapy following polychemotherapy Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 164(2): 68-72
2015: P117) Outcomes, Patterns of Failures, and Toxicity for Patients Diagnosed With Pulmonary Metastases Treated With Stereotactic Body Ablative Radiotherapy (SABR Oncology 29(4 Suppl. 1)
De Wildt, D.J.; de Jong, Y.; Hillen, F.C.; Steerenberg, P.A.; van Hoesel, Q.G. 1985: Cardiovascular effects of doxorubicin-induced toxicity in the intact Lou/M Wsl rat and in isolated heart preparations Journal of Pharmacology and Experimental Therapeutics 235(1): 234-240
Mostafa, A.M.; Nagi, M.N.; Al Rikabi, A.C.; Al-Shabanah, O.A.; El-Kashef, H.A. 1999: Protective effect of aminoguanidine against cardiovascular toxicity of chronic doxorubicin treatment in rats Research Communications in Molecular Pathology and Pharmacology 106(3): 193-202
Worek, F.; Szinicz, L. 1993: Investigation of acute cardiovascular and respiratory toxicity of HLö 7 dimethanesulfonate and HI 6 dichloride in anaesthetized guinea-pigs Pharmacology and Toxicology 73(2): 91-95
Hellenbrecht, D.; Enenkel, J. 1984: Estimation of the nonspecific cardiovascular toxicity of beta-adrenoceptor blocking drugs with different hydrophobic properties in the cat Arzneimittel-Forschung 34(9): 980-983
Veerasarn, V.; Phromratanapongse, P.; Suntornpong, N.; Lorvidhaya, V.; Sukthomya, V.; Chitapanarux, I.; Tesavibul, C.; Swangsilpa, T.; Khorprasert, C.; Shotelersuk, K.; Kongthanarat, Y.; Panichevaluk, A.; Chiewvit, S.; Pusuwan, P.; Aekmahachai, M.; Ratchadara, S.; Sirilipoche, S.; Saengsuda, Y. 2006: Effect of Amifostine to prevent radiotherapy-induced acute and late toxicity in head and neck cancer patients who had normal or mild impaired salivary gland function Journal of the Medical Association of Thailand 89(12): 2056-2067
Heath, A.; Svensson, C.; Mårtensson, E. 1985: Thioridazine toxicity--an experimental cardiovascular study of thioridazine and its major metabolites in overdose Veterinary and Human Toxicology 27(2): 100-105